Buyer	NHS England — not a council we hold
Supplier	Bio Products Laboratory Ltd
Supplier	CSL Behring UK Ltd
Supplier	GRIFOLS UK LIMITED
Supplier	LFB
Supplier	Octapharma Limited
Supplier	Takeda UK Ltd

NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin Offer reference number: CM/PHS/23/5703 The period of the framework is 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months.

Runs	1 Apr 2025 to 31 Dec 2027
OCID	ocds-b5fd17-63eefe2c-af75-4320-8392-e35c49eff8b9
Notice	Read it on Contracts Finder

Figures are as published An award value in OCDS may be a framework ceiling rather than a sum anyone expects to spend, so a large figure here is not evidence of a large purchase.